#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4837920	Binding	Inhibition of wild type HIV1 protease using Arg-Glu (EDANS)-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-Lys(DABCYL)-Arg as substrate preincubated for 20 to 30 mins followed by substrate addition and measured for 10 mins by FRET assay	Human immunodeficiency virus 1	22	ALA4837199	single protein format	Scientific Literature
2.	ALA4837921	Functional	Antiviral activity against HIV1	Human immunodeficiency virus 1	22	ALA4837199	organism-based format	Scientific Literature
3.	ALA4837922	ADME	Cytotoxicity against HEK293T cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay	Homo sapiens	22	ALA4837199	cell-based format	Scientific Literature
4.	ALA4837923	Toxicity	Selectivity index, ratio of CC50 for cytotoxicity against HEK293T cells to IC50 of antiviral activity against HIV1		16	ALA4837199	cell-based format	Scientific Literature
5.	ALA4837924	Functional	Antiviral activity against HIV1 Env-deficient VSV-G pseudotyped virus infected in human SUP-T1 cells infected with supernatant of compound treated virus-producing 293T cells assessed as inhibition of late stage viral production at 10 uM treated for 48 hrs with virus-producing 293T cells followed by SUP-T1 cells infection for 48 hrs by single-round infection luciferase assay relative to control	Human immunodeficiency virus 1	9	ALA4837199	organism-based format	Scientific Literature
6.	ALA4837925	Functional	Antiviral activity against HIV1 (NL4-3) Env-deficient VSV-G pseudotyped virus infected in human SUP-T1 cells assessed as inhibition of early stage viral production at 10 uM measured after 48 hrs by luciferase assay relative to control	Human immunodeficiency virus 1	2	ALA4837199	organism-based format	Scientific Literature
7.	ALA4837927	Functional	Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as reduction in viral replication by measuring reduction in p24 Gag production by chemiluminescent-EIA	Human immunodeficiency virus 1	2	ALA4837199	organism-based format	Scientific Literature
8.	ALA4837928	Functional	Antiviral activity against DRV resistant HIV1 infected in human MT4 cells assessed as reduction in viral replication by measuring reduction in p24 Gag production by chemiluminescent-EIA	Human immunodeficiency virus 1	2	ALA4837199	organism-based format	Scientific Literature
9.	ALA4837929	Functional	Antiviral activity against HIV1 subtype C isolate 11928	Human immunodeficiency virus 1	2	ALA4837199	organism-based format	Scientific Literature
10.	ALA4837930	Functional	Antiviral activity against HIV1 subtype C isolate 11929	Human immunodeficiency virus 1	2	ALA4837199	organism-based format	Scientific Literature
11.	ALA4837931	Functional	Antiviral activity against HIV1 subtype C isolate 11941	Human immunodeficiency virus 1	2	ALA4837199	organism-based format	Scientific Literature
12.	ALA4837932	Functional	Antiviral activity against HIV1 subtype C isolate-plndie	Human immunodeficiency virus 1	2	ALA4837199	organism-based format	Scientific Literature
13.	ALA4837933	Functional	Resistance index, ratio of IC50 for DRV resistant HIV1 infected in human MT4 cells to IC50 for HIV1 NL4-3 infected in human MT4 cells		2	ALA4837199	cell-based format	Scientific Literature
14.	ALA4837934	Binding	Potency index, ratio of DRV Ki to test compound Ki for inhibition of wild type HIV1 protease using Arg-Glu (EDANS)-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-Lys(DABCYL)-Arg as substrate preincubated for 20 to 30 mins followed by substrate addition and measured for 10 mins by FRET assay	Human immunodeficiency virus 1	1	ALA4837199	single protein format	Scientific Literature